Julia Malkowski, ND, DC, BSc, and clinical education doctor for Doctors Data suggests the GI360 panel that provides individualized biomarker data regarding microbiome dysbiosis, diversity, phyla abundance, key bacteria, and metabolites, such as short chain fatty acids (SCFAs)
You should inject the medication into subcutaneous or pinchable fat on the belly, upper arm, or upper thigh
However, products promising to replace or serve as an alternative to or enhance the efficacy or safety of approved GLP-1 drugs would be unlawful
The starting dose of tirzepatide is 2.5 mg once a week, and after 4 weeks, the dose is increased to the therapeutic dose of 5 mg and administered subcutaneously in patients with T2D